I-QARE DS-W BLOOD GLUCOSE MONITORING SYSTEM

System, Test, Blood Glucose, Over The Counter

ALLIANCE INTERNATIONAL CO., LTD.

The following data is part of a premarket notification filed by Alliance International Co., Ltd. with the FDA for I-qare Ds-w Blood Glucose Monitoring System.

Pre-market Notification Details

Device IDK132663
510k NumberK132663
Device Name:I-QARE DS-W BLOOD GLUCOSE MONITORING SYSTEM
ClassificationSystem, Test, Blood Glucose, Over The Counter
Applicant ALLIANCE INTERNATIONAL CO., LTD. NO.54 YING TAO RD. YING DISTRICT New Taipei City, 239,  TW 23942
ContactJen Ke-min
CorrespondentJen Ke-min
ALLIANCE INTERNATIONAL CO., LTD. NO.54 YING TAO RD. YING DISTRICT New Taipei City, 239,  TW 23942
Product CodeNBW  
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2013-08-26
Decision Date2015-04-20
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
16971292001628 K132663 000
16971292006968 K132663 000
16971292006975 K132663 000
06971292006985 K132663 000
16971292006999 K132663 000
16971292007002 K132663 000
16971292007019 K132663 000
16971292007026 K132663 000
16971292007033 K132663 000
16971292001864 K132663 000
16971292001611 K132663 000
16971292006951 K132663 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.